Add to favorites:
Share:
The Challenge-Driven GenAI4EU Booster is a funding call under the Horizon Europe framework focused on advancing Generative AI (GenAI) in strategic sectors such as aerospace and pharma/drug development. This initiative supports innovative projects to boost Europe’s GenAI developer community and foster the adoption of trustworthy GenAI solutions, enhancing competitiveness in these key sectors.
The call employs a challenge-driven approach, encouraging collaboration between user industries, AI developers, and research entities to define and address impactful use cases. Proposals will focus on pre-competitive solutions, with a staged process for development. Third-party participants, including SMEs and startups, will compete in progressive phases with increasing complexity. At the first stage, 20 participants will receive funding to prepare for subsequent phases. In the final stages, selected participants will collaborate with the consortium for further funding and an opportunity to establish contracts or partnerships with the industry.
The core consortium will design the methodology, define call specifications, and oversee evaluation criteria, dissemination, and infrastructure support. Emphasis is placed on fostering visibility, attracting sponsorships, and supporting participants throughout the project. Collaboration with related initiatives and integration with the AI-on-Demand platform is also required.
This action aims to showcase the potential of GenAI in achieving transformative impacts, driving technological advancements, and setting new benchmarks in aerospace and pharma sectors.
Opening: 10 Jun 2025
Deadline(s): 13 Nov 2025
Data provided by Sciencebusiness.net
This funding opportunity represents a pre-agreed draft that has not yet been officially approved by the European Commission. The final, approved version is expected to be published in the first quarter of 2025. This draft is provided for informational purposes and may be used to preliminarily form consortia and develop project ideas, but it is offered without any guarantees or warranties.
Expected Outcome
- Significant technological progress in aerospace and pharma/drugs.
- Increased visibility and competitiveness of Europe’s GenAI community.
- Greater adoption of GenAI in targeted sectors via demonstrated achievements.
- Enhanced partnerships between industry and AI developers.
Scope
- Boost the European GenAI developer community.
- Foster trustworthy GenAI adoption in aerospace and pharma/drugs.
- Encourage strategic industry participation in projects for impactful results.
- Use a challenge-driven, staged development process with financial incentives.
- Promote pre-competitive solutions with future exploitation commitments.